Indoco Remedies Limited has informed the Exchange regarding a press release dated October 11, 2024, titled "Indoco informs receipt of regulatory status from USFDA for our facilities located at Goa Plant-II & III (Facility), following an inspection conducted by USFDA in July 2024. The USFDA has determined that the inspection classification of this Facility remains as Official Action Indicated (OAI).".